In addition, we found that liver fibrosis is the most significant risk factor for all-cause mortality in patients with MASLD, and that high CRP concentration is the most significant risk factor for all-cause mortality in those with NAFLD. Here, CRP is linked to metabolic dysfunction-associated steatotic liver disease.